Epithelial V-like Antigen 1 Promotes Hepatocellular Carcinoma Growth and Metastasis Via the ERBB-PI3K-AKT Pathway

Overview

Journal Cancer Sci

Specialty Oncology

Date 2020 Jan 31

PMID 31997489

Citations 11

Authors

Qianzhi Ni

Zhenhua Chen

Qianwen Zheng

Dong Xie

Jing-Jing Li

Shuqun Cheng

Xingyuan Ma

Affiliations

Soon will be listed here.

Abstract

The role of epithelial V-like antigen 1 (EVA1) has been well studied in thymic development and homostasis; however, its putative relationship with cancer remains largely unknown. Therefore, here we investigated the role of EVA1 in hepatocellular carcinoma. Interestingly, EVA1 expression was significantly increased in hepatocellular carcinoma (HCC) and was also associated with a poor prognosis and recurrence in HCC patients. Overexpression of EVA1 promoted cell growth, invasion and migration in vitro. Consistently, knockdown of EVA1 expression inhibited proliferation and migration in vitro, while repressing metastasis of HCC cells in vivo. RNA-seq analysis indicated that EVA1 is able to upregulate the expression of genes in the ERBB3-PI3K pathway. Accordingly, an increased level of AKT phosphorylation was detected in HCC cells after EVA1 overexpression. LY294002, a PI3K inhibitor, inhibited AKT phosphorylation and rescued the tumor-promoting effect of EVA1 overexpression. Altogether, the present study has revealed the oncogenic role of EVA1 during HCC progression and metastasis through the ERBB-PI3K-AKT signaling pathway, reiterating the potential use of EVA1 as a therapeutic target and/or prognostic marker for HCC.

Citing Articles

EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.

Hou J, Uejima T, Tanaka M, Son Y, Hanada K, Kukimoto-Niino M Neuro Oncol. 2024; 27(3):682-694.

PMID: 39470407 PMC: 11889714. DOI: 10.1093/neuonc/noae226.

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway.

Fei D, Wang F, Wang Y, Chen J, Chen S, Fan L Mol Cancer. 2024; 23(1):159.

PMID: 39107843 PMC: 11302160. DOI: 10.1186/s12943-024-02074-z.

Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.

Qiang Z, Wan J, Chen X, Wang H Transl Cancer Res. 2024; 13(6):3156-3178.

PMID: 38988928 PMC: 11231811. DOI: 10.21037/tcr-24-837.

Identification and Characterization of Metastasis-Initiating Cells in ESCC in a Multi-Timepoint Pulmonary Metastasis Mouse Model.

Wong C, Zhang Y, Ru B, Wang S, Zhou H, Lin J Adv Sci (Weinh). 2024; 11(30):e2401590.

PMID: 38864342 PMC: 11321633. DOI: 10.1002/advs.202401590.

PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A.

Lin W, Wang K, Mo J, Wang L, Song Z, Jiang H Cancer Med. 2023; 12(13):14413-14425.

PMID: 37212524 PMC: 10358214. DOI: 10.1002/cam4.6068.

References

Iacovelli S, Iosue I, Cesare S, Guttinger M . Lymphoid EVA1 expression is required for DN1-DN3 thymocytes transition. PLoS One. 2009; 4(10):e7586. PMC: 2761490. DOI: 10.1371/journal.pone.0007586. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Mraz M, Chen L, Rassenti L, Ghia E, Li H, Jepsen K . miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. 2014; 124(1):84-95. PMC: 4125356. DOI: 10.1182/blood-2013-09-527234. View

Li J, Yin H, Guan D, Zhao J, Feng Y, Deng Y . Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis. Br J Cancer. 2018; 118(10):1337-1348. PMC: 5959946. DOI: 10.1038/s41416-018-0077-y. View

Garabatos N, Blanco J, Fandos C, Lopez E, Santamaria P, Ruiz A . A monoclonal antibody against the extracellular domain of mouse and human epithelial V-like antigen 1 reveals a restricted expression pattern among CD4- CD8- thymocytes. Monoclon Antib Immunodiagn Immunother. 2014; 33(5):305-11. PMC: 4216515. DOI: 10.1089/mab.2014.0030. View

Difilippantonio S, Chen Y, Pietas A, Schluns K, Pacyna-Gengelbach M, Deutschmann N . Gene expression profiles in human non-small and small-cell lung cancers. Eur J Cancer. 2003; 39(13):1936-47. DOI: 10.1016/s0959-8049(03)00419-2. View

Hucz J, Kowalska M, Jarzab M, Wiench M . [Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer]. Endokrynol Pol. 2006; 57 Suppl A:18-25. View

Shi D, Li L, Bian X, Shi X, Lu L, Zhou H . miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. J Exp Clin Cancer Res. 2018; 37(1):294. PMC: 6264612. DOI: 10.1186/s13046-018-0957-2. View

Peng Y, Zhu Y, Yin L, Wei J, Liu X, Zhu X . PIK3R3 Promotes Metastasis of Pancreatic Cancer via ZEB1 Induced Epithelial-Mesenchymal Transition. Cell Physiol Biochem. 2018; 46(5):1930-1938. DOI: 10.1159/000489382. View

10.

Nicolau-Neto P, Meireles Da Costa N, de Souza Santos P, Gonzaga I, Ferreira M, Guaraldi S . Esophageal squamous cell carcinoma transcriptome reveals the effect of on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway. Oncotarget. 2018; 9(24):16634-16647. PMC: 5908275. DOI: 10.18632/oncotarget.24621. View

11.

Singh R, Parveen M, Basgen J, Fazel S, Meshesha M, Thames E . Increased Expression of Beige/Brown Adipose Markers from Host and Breast Cancer Cells Influence Xenograft Formation in Mice. Mol Cancer Res. 2015; 14(1):78-92. PMC: 4749269. DOI: 10.1158/1541-7786.MCR-15-0151. View

12.

Jiang H, Ma N, Shang Y, Zhou W, Chen T, Guan D . Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2016; 482(4):1048-1053. DOI: 10.1016/j.bbrc.2016.11.156. View

13.

Kallin A, Johannessen L, Cani P, Marbehant C, Essaghir A, Foufelle F . SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma. J Lipid Res. 2007; 48(7):1628-36. DOI: 10.1194/jlr.M700136-JLR200. View

14.

Sun J, Fu L . [IL-6 promotes gastric cancer cell proliferation and EMT through regulating miR-152/PIK3R3 pathway]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017; 42(11):1241-1247. DOI: 10.11817/j.issn.1672-7347.2017.11.001. View

15.

Aasrum M, Odegard J, Sandnes D, Christoffersen T . The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes. Biochim Biophys Acta. 2013; 1833(12):3286-3294. DOI: 10.1016/j.bbamcr.2013.10.004. View

16.

Ramena G, Yin Y, Yu Y, Walia V, Elble R . CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation. PLoS One. 2016; 11(3):e0147489. PMC: 4773014. DOI: 10.1371/journal.pone.0147489. View

17.

Laursen K, Wong P, Gudas L . Epigenetic regulation by RARα maintains ligand-independent transcriptional activity. Nucleic Acids Res. 2011; 40(1):102-15. PMC: 3245912. DOI: 10.1093/nar/gkr637. View

18.

Ohtsu N, Nakatani Y, Yamashita D, Ohue S, Ohnishi T, Kondo T . Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-κB Signaling Pathway. Cancer Res. 2015; 76(1):171-81. DOI: 10.1158/0008-5472.CAN-15-0884. View

19.

Ni Q, Chen Z, Zheng Q, Xie D, Li J, Cheng S . Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway. Cancer Sci. 2020; 111(5):1500-1513. PMC: 7226218. DOI: 10.1111/cas.14331. View

20.

Jones R, Gordus A, Krall J, MacBeath G . A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2005; 439(7073):168-74. DOI: 10.1038/nature04177. View